Industry innovation shines at ASH
This article was originally published in Scrip
Executive Summary
The 52nd Annual American Society of Hematology Meeting and Exposition (ASH 2010), held on 10-13 December in San Diego, California, showed a reassuring level of industry innovation, finds a new analysis by Citeline oncology analysts Laurie Withington and Michael Spooner of the clinical trials reported there that are included in Citeline’s TrialTrove portfolio.